Arrowhead Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (21 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/11/2026 | 968 | 0.0% | 14,588 | 12/31/2025 |
| 2025 Q3 | 11/13/2025 | 327 | 0.0% | 9,491 | 9/30/2025 |
| 2024 Q3 | 11/12/2024 | 203 | 0.0% | 10,491 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 246 | 0.0% | 9,481 | 6/30/2024 |
| 2024 Q1 | 5/13/2024 | 279 | 0.0% | 9,752 | 3/31/2024 |
| 2023 Q4 | 2/9/2024 | 303 | 0.0% | 9,896 | 12/31/2023 |
| 2023 Q3 | 11/13/2023 | 257 | 0.0% | 9,558 | 9/30/2023 |
| 2023 Q1 | 5/12/2023 | 254 | 0.0% | 10,014 | 3/31/2023 |
| 2022 Q4 | 2/10/2023 | 473 | 0.0% | 11,667 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 399 | 0.0% | 12,076 | 9/30/2022 |
| 2022 Q2 | 8/11/2022 | 342 | 0.0% | 9,704 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 431 | 0.0% | 9,378 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 480 | 0.0% | 7,244 | 12/31/2021 |
| 2021 Q3 | 11/10/2021 | 378 | 0.0% | 6,040 | 9/30/2021 |
| 2021 Q2 | 8/9/2021 | 544 | 0.0% | 6,572 | 6/30/2021 |
| 2021 Q1 | 5/14/2021 | 435 | 0.0% | 6,572 | 3/31/2021 |
| 2020 Q4 | 2/11/2021 | 512 | 0.0% | 6,675 | 12/31/2020 |
| 2020 Q3 | 11/12/2020 | 504 | 0.0% | 11,670 | 9/30/2020 |
| 2020 Q2 | 8/13/2020 | 555 | 0.0% | 12,845 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 455 | 0.0% | 15,742 | 3/31/2020 |
| 2019 Q4 | 2/12/2020 | 909 | 0.0% | 14,359 | 12/31/2019 |